✦ LIBER ✦
Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip®) to adults aged ≥60 years: An open-label, randomised trial
✍ Scribed by Zimmermann, Ulrich; Gavazzi, Gaëtan; Richard, Patrick; Eymin, Cécile; Soubeyrand, Benoît; Baudin, Martine
- Book ID
- 123179397
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 420 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0264-410X
No coin nor oath required. For personal study only.